patient_id	feature_display	tested_subfeature	therapy_name	n_mut	n_wt	n_mut_tested	n_wt_tested	mut_ic50_median	mut_ic50_mean	mut_ic50_std	wt_ic50_median	wt_ic50_mean	wt_ic50_std	pvalue_mww	statistic
MEL-IPI_Pat82	BRAF p.V600E (Missense)	BRAF	Dabrafenib	264	1559	136	621	34.824	120.732	228.705	121.915	244.298	422.653	2.322e-12	58428.0
MEL-IPI_Pat82	BRAF p.V600E (Missense)	BRAF Somatic Variant	Dabrafenib	184	1639	98	659	19.092	80.76	176.13	120.697	243.118	416.712	7.627e-17	49130.0
MEL-IPI_Pat82	BRAF p.V600E (Missense)	BRAF Somatic Variant Missense	Dabrafenib	170	1653	89	668	19.04	82.289	184.013	119.74	240.726	414.446	6.330e-16	45390.0
MEL-IPI_Pat82	BRAF p.V600E (Missense)	BRAF Somatic Variant Missense p.V600E	Dabrafenib	101	1722	49	708	3.725	16.282	39.616	118.217	236.343	407.192	5.518e-23	31960.0
MEL-IPI_Pat82	BRAF p.V600E (Missense)	BRAF	Trametinib	264	1559	137	634	0.516	5.862	27.545	2.112	7.605	32.168	2.344e-09	57546.5
MEL-IPI_Pat82	BRAF p.V600E (Missense)	BRAF Somatic Variant	Trametinib	184	1639	99	672	0.364	4.887	30.17	2.152	7.65	31.568	9.083e-13	48043.5
MEL-IPI_Pat82	BRAF p.V600E (Missense)	BRAF Somatic Variant Missense	Trametinib	170	1653	90	681	0.271	5.095	31.639	2.147	7.586	31.365	2.900e-13	45139.0
MEL-IPI_Pat82	BRAF p.V600E (Missense)	BRAF Somatic Variant Missense p.V600E	Trametinib	101	1722	50	721	0.085	0.659	1.336	2.059	7.755	32.406	1.793e-14	29698.0
MEL-IPI_Pat82	BRAF p.D594Y (Missense)	BRAF	Dabrafenib	264	1559	136	621	34.824	120.732	228.705	121.915	244.298	422.653	2.322e-12	58428.0
MEL-IPI_Pat82	BRAF p.D594Y (Missense)	BRAF Somatic Variant	Dabrafenib	184	1639	98	659	19.092	80.76	176.13	120.697	243.118	416.712	7.627e-17	49130.0
MEL-IPI_Pat82	BRAF p.D594Y (Missense)	BRAF Somatic Variant Missense	Dabrafenib	170	1653	89	668	19.04	82.289	184.013	119.74	240.726	414.446	6.330e-16	45390.0
MEL-IPI_Pat82	BRAF p.D594Y (Missense)	BRAF Somatic Variant Missense p.D594Y	Dabrafenib	0	1823	0	757				106.703	222.099	397.61	nan	
MEL-IPI_Pat82	BRAF p.D594Y (Missense)	BRAF	Trametinib	264	1559	137	634	0.516	5.862	27.545	2.112	7.605	32.168	2.344e-09	57546.5
MEL-IPI_Pat82	BRAF p.D594Y (Missense)	BRAF Somatic Variant	Trametinib	184	1639	99	672	0.364	4.887	30.17	2.152	7.65	31.568	9.083e-13	48043.5
MEL-IPI_Pat82	BRAF p.D594Y (Missense)	BRAF Somatic Variant Missense	Trametinib	170	1653	90	681	0.271	5.095	31.639	2.147	7.586	31.365	2.900e-13	45139.0
MEL-IPI_Pat82	BRAF p.D594Y (Missense)	BRAF Somatic Variant Missense p.D594Y	Trametinib	0	1823	0	771				1.844	7.295	31.386	nan	
MEL-IPI_Pat82	JAK3 p.S622N (Missense)	JAK3	Ruxolitinib	92	1731	58	670	125.284	170.224	156.01	126.74	195.163	267.172	0.952	19523.0
MEL-IPI_Pat82	JAK3 p.S622N (Missense)	JAK3 Somatic Variant	Ruxolitinib	67	1756	46	682	112.944	168.732	161.687	126.85	194.825	265.403	0.787	16059.0
MEL-IPI_Pat82	JAK3 p.S622N (Missense)	JAK3 Somatic Variant Missense	Ruxolitinib	66	1757	45	683	114.78	170.154	163.222	126.802	194.693	265.231	0.815	15688.0
MEL-IPI_Pat82	JAK3 p.S622N (Missense)	JAK3 Somatic Variant Missense p.S622N	Ruxolitinib	0	1823	0	728				126.74	193.176	260.077	nan	
MEL-IPI_Pat82	BRAF p.E611* (Nonsense)	BRAF	Dabrafenib	264	1559	136	621	34.824	120.732	228.705	121.915	244.298	422.653	2.322e-12	58428.0
MEL-IPI_Pat82	BRAF p.E611* (Nonsense)	BRAF Somatic Variant	Dabrafenib	184	1639	98	659	19.092	80.76	176.13	120.697	243.118	416.712	7.627e-17	49130.0
MEL-IPI_Pat82	BRAF p.E611* (Nonsense)	BRAF Somatic Variant Nonsense	Dabrafenib	2	1821	1	756	69.152	69.152		106.814	222.301	397.834	0.702	462.0
MEL-IPI_Pat82	BRAF p.E611* (Nonsense)	BRAF Somatic Variant Nonsense p.E611*	Dabrafenib	0	1823	0	757				106.703	222.099	397.61	nan	
MEL-IPI_Pat82	BRAF p.E611* (Nonsense)	BRAF	Trametinib	264	1559	137	634	0.516	5.862	27.545	2.112	7.605	32.168	2.344e-09	57546.5
MEL-IPI_Pat82	BRAF p.E611* (Nonsense)	BRAF Somatic Variant	Trametinib	184	1639	99	672	0.364	4.887	30.17	2.152	7.65	31.568	9.083e-13	48043.5
MEL-IPI_Pat82	BRAF p.E611* (Nonsense)	BRAF Somatic Variant Nonsense	Trametinib	2	1821	1	770	0.006	0.006		1.844	7.305	31.406	0.107	744.5
MEL-IPI_Pat82	BRAF p.E611* (Nonsense)	BRAF Somatic Variant Nonsense p.E611*	Trametinib	0	1823	0	771				1.844	7.295	31.386	nan	
MEL-IPI_Pat82	BRAF  (Splice Site)	BRAF	Dabrafenib	264	1559	136	621	34.824	120.732	228.705	121.915	244.298	422.653	2.322e-12	58428.0
MEL-IPI_Pat82	BRAF  (Splice Site)	BRAF Somatic Variant	Dabrafenib	184	1639	98	659	19.092	80.76	176.13	120.697	243.118	416.712	7.627e-17	49130.0
MEL-IPI_Pat82	BRAF  (Splice Site)	BRAF Somatic Variant Splice Site	Dabrafenib	0	1823	0	757				106.703	222.099	397.61	nan	
MEL-IPI_Pat82	BRAF  (Splice Site)	BRAF	Trametinib	264	1559	137	634	0.516	5.862	27.545	2.112	7.605	32.168	2.344e-09	57546.5
MEL-IPI_Pat82	BRAF  (Splice Site)	BRAF Somatic Variant	Trametinib	184	1639	99	672	0.364	4.887	30.17	2.152	7.65	31.568	9.083e-13	48043.5
MEL-IPI_Pat82	BRAF  (Splice Site)	BRAF Somatic Variant Splice Site	Trametinib	0	1823	0	771				1.844	7.295	31.386	nan	
